is a partner in Kirkland’s IP litigation team in London. He has a broad practice that covers a wide range of fields, but is particularly noted for his experience in high-stakes trade secrets, high tech and telecommunications, and life sciences patent litigation, particularly in the pharmaceutical industry. Daniel is regularly called upon to assist clients in devising, co-ordinating and executing strategies for complex multi-jurisdictional disputes at an international scale, and to identify and navigate trade secret risks. His case experience covers a broad range of technical fields, including oncology, molecular diagnostics and biostatistics, medical lasers, integrated circuit and mobile telecommunications technology, often involving issues at the cutting edge of the law, notably in relation to second medical-use patents. Daniel is vice-chair of AIPPI’s standing committee on biotechnology.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.